¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"cardiac rate"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • exposure rate
    ³ëÃâ·ü, ÇÇÆø·ü
  • exposure rate constant
    ÇÇÆø·ü»ó¼ö
  • early neonatal mortality rate
    Á¶±â½Å»ý¾Æ»ç¸Á·ü
  • energy metabolic rate
    ¿¡³ÊÁö´ë»çÀ²
  • erythrocyte sedimentation rate
    ÀûÇ÷±¸Ä§°­¼Óµµ, Ç÷ħ¼Óµµ
  • fatality rate
    Ä¡¸í·ü
  • fertility rate
    »ý½Ä·ü
  • fetal death rate
    žƻç¸Á·ü
  • fetal heart rate
    žƽɹڼö
  • filtration rate
    ¿©°úºñ, ¿©°úÀ², ¿©°ú¼Óµµ
  • five-year survival rate
    ¿À³â»ýÁ¸À²
  • fixed rate pacemaker
    °íÁ¤¼Óµµ¹Úµ¿Á¶À²±â
  • flow rate
    1. À¯¼Ó 2. À¯·®
  • fractional fibrinogen catabolic rate
    ºÐȹº°¼¶À¯¼Ò¿ø´ë»çÀ²
  • frame rate
    È­¸é¹ß»ý·ü, È­¸éÀ²
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • dose rate
    ¼±·®·ü
  • dose rate effect
    ¼±·®À²È¿°ú
  • dose rate meter
    ¼±·®À²°è, ¼±·®·üÃøÁ¤±â
  • dose rate variation
    ¼±·®·üº¯ÀÌ
  • early neonatal mortality rate
    ½Å»ý¾Æ»ç¸Á·ü
  • egg negative conversion rate
    Ãæ¶õÀ½ÀüÀ²
  • egg reduction rate
    Ãæ¶õ°¨¼ÒÀ²
  • energy fluence rate
    ¿¡³ÊÁöÇ÷ç¾ð½ºÀ², ¿¡³ÊÁö¿µÇâ·ü
  • energy metabolic rate
    ¿¡³ÊÁö´ë»çÀ²
  • erythrocyte sedimentation rate
    ÀûÇ÷±¸Ä§°­¼Óµµ, Ç÷ħ¼Óµµ
  • exponential growth rate
    ´ë¼öÁõ½Ä·ü, Áö¼öÁõ½Ä·ü
  • exposure rate
    ÇÇÆø·ü
  • rate limiting enzyme
    ¼ÓµµÁ¶ÀýÈ¿¼Ò
  • fatality rate
    Ä¡¸í·ü
  • fertility rate
    »ý½Ä·ü, ¼öÅÂÀ²
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • maximum mid-expiratory flow rate
    ÃÖ´ëÁß°£È£±â À¯Ãâ¼Óµµ
  • maximum voiding rate =MVR
    ÃÖ°í¹è´¢À²(õÌÍÔÛÉèñëÒ).
  • mean airflow rate
    ¹ß¼º½Ã È£±â·ùÀ²
  • metabolic clearance rate =MCR
    ´ë»çŬ¸®¾î·±½ºÀ².
  • metabolic rate
    ´ë»çÀ²(ÓÛÞóëÒ).
  • metabolic rate
    ´ë»çÀ²
  • molecular tumbling rate
    ºÐÀÚ ÅÒºí¸µ À²
  • morbidity rate
    ÀÌȯÀ²(ËöÌ·Ëô).
  • mortality (rate) curve
    »ç¸Á·ü°î¼±(ÊÙË­ËÛ).
  • mortality rate
    »ç¸Á·ü(Ë×ËÎËô).
  • mortality rate
    »ç¸Á·ü(»ç¸ÁÀ²).
  • mortality rate
    »ç¸Á·ü(ÞÝØÌëÒ).
  • mutation rate
    (µ¹¿¬)º¯ÀÌÀ².
  • natality =birth rate
    Ãâ»ý·ü(̧Ë×Ëô).
  • neonatal death rate
    ½Å»ý¾Æ»ç¸Á·ü(~ëÒ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
RRR regular rhythm and rate; renin release rate (or ratio)
SER sebum excretion rate; sensitizer enhancement ratio; sensory evoked response; service; smooth endopla...
SR sarcoplasmic reticulum; saturation recovery; scanning radiometer; screen; secretion rate; sedimentat...
TPR temperature, pulse, and respiration; testosterone production rate; third party reimbursement; total ...
UFR ultrafiltration rate; urine filtration rate
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
CD cardiac denervated
CF cardiac failure
NCCP non-cardiac chest pain
TD(co) thermodilution cardiac output
5c ER 5c Exceeding Rate
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • cardiac tonus
    ½ÉÀå ±äÀå
    ±ÙÀ°ÀÇ Áö¼ÓÀûÀÎ °æµµÀÇ ¼öÃàÀ¸·Î °ñ°Ý±Ù¿¡ À־ ÀÚ¼¼ÀÇ À¯Áö ¹× Ç÷¾×ÀÇ ½ÉÀåÀ¸·ÎÀÇ ±ÍȯÀ» µµ¿ÍÁØ´Ù.
  • cardiac vagal afferents
    ½ÉÀå ¹ÌÁÖ½Å°æ ±¸½É ¼¶À¯
  • cardiac vein
    ½É Á¤¸Æ
    ¿©·¯ ±â°ü ȤÀº ºÎºÐ¿¡¼­ ½ÉÀåÀ¸·Î µÇµ¹¾Æ°¡´Â Ç÷¾×ÀÌ È帣´Â Ç÷°ü.
  • cardiac work load
    ½É ÀÛ¾÷ ºÎÇÏ
  • cine cardiac magnetic resonance imaging
    ¿µÈ­ ½ÉÀå Àڱ⠰ø¸í ¿µ»ó
  • closed chest cardiac massage
    ÆóÈä ½ÉÀå ¸¶»çÁö, ºñ°³Èä ½ÉÀå ¸¶»çÁö, ü¿Ü ½É ¸¶»çÁö
  • electric cardiac axis
    Àü±âÀû ½ÉÀå Ãà
  • inferior cervical cardiac branches
    ¾Æ·¡ ¸ñ ½ÉÀå °¡Áö
  • internal cardiac massage
    ü³» ½É¸¶»çÁö, °³Èä½É ¸¶»çÁö
  • multiphase cardiac imaging
    ´ÙÁß À§»ó ½ÉÀå ¿µ»ó
  • neuro- ½Å°æ, ½Å°æ Á¶Á÷ ¶Ç´Â ½Å°æ°è¿ÍÀÇ °ü°è¸¦ ³ªÅ¸³»´Â Á¢µÎ¾î.

    neuro-cardiac

    ½Å°æ ½ÉÀåÀÇ
    ½Å°æ°è ¹× ½ÉÀå¿¡ °ü°èµÈ.
  • open chest cardiac massage
    °³Èä½É ¸¶»çÁö, °³Èä½Ä ½É ¸¶»çÁö, °³Èä ½ÉÀå ¸¶»çÁö, °³Èä½Ä ½ÉÀå ¸¶»çÁö, °³Èä½É ¸¶»çÁö¹ý
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
lethality rate <statistics> The proportion of deaths in a population or to a specific number of the population.
(18 Nov 1997)
lowest achievable emissions rate (LAER) Used to describe air emissions control technology. A rate of emissions defined by the permitting agency. LEAR sets emission limits for non-attainment areas.
(05 Dec 1998)
abnormal cleavage of cardiac valve Congenital malformation of a valve leaflet with a defect extending from the free margin.
(05 Mar 2000)
anterior cardiac veins Two or three small veins in the anterior wall of the right ventricle opening directly into the right atrium independently of the coronary sinus.
Synonym: venae cordis anteriores.
(05 Mar 2000)
area of cardiac dullness A triangular area determined by percussion of the front of the chest; it corresponds to the part of the heart that is not covered by lung tissue.
(05 Mar 2000)
cardiac <cardiology> Pertaining to the heart.
Origin: L. Cardiacus from Gr. Kardiakos
(16 Dec 1997)
cardiac accident Sudden cardiac catastrophe, such as may result from coronary occlusion.
(05 Mar 2000)
cardiac albuminuria Albuminuria caused by congestive heart failure.
(05 Mar 2000)
cardiac alternation The occurrence of any cardiac phenomenon every other beat.
(05 Mar 2000)
cardiac aneurysm Thinning, stretching, and bulging of a weakened ventricular wall, usually as a result of myocardial infarction; rarely postinflammatory or congenital.
Synonym: mural aneurysm, ventricular aneurysm.
(05 Mar 2000)
cardiac arrest This refers to the complete cessation of cardiac activity (heartbeat).
(27 Sep 1997)
cardiac arrhythmia A disturbance the electrical activity of the heart that manifests as an abnormality in heart rate or heart rhythm. Patients with a cardiac arrhythmia may experience a wide variety of symptoms ranging from palpitations to fainting.
(27 Sep 1997)
cardiac asthma An asthmatic attack, the bronchoconstriction being secondary to the pulmonary congestion and oedema of left ventricular failure.
(05 Mar 2000)
cardiac ballet Short runs of cardiac dysrhythmia consisting of uniform sequences of repetitive multiform extrasystoles; so called from its undulating appearance, originally described by Bellet.
See: torsade de pointes.
(05 Mar 2000)
cardiac blood pool imaging This noninvasive test uses radioactive tracers to delineate the hearts chambers and major vessels. It may be used to detect a heart attack, heart muscle function and coronary artery disease. The patient receives a radioactive tracer by injection (into a vein) and then the heart is imaged using a gamma camera. The heart is imaged before and after exercise. This test may be used to detect and evaluate atrial septal defect, dilated cardiomyopathy, congestive heart failure, cardiomyopathy, Lyme disease (secondary), mitral stenosis and superior vena cava syndrome.
(27 Sep 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
ÅëÇÕ°Ë»ö ¿Ï·á